BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• BioCapital

  Advarra Expands Review Capabilities for Cosmetics Research

  Advarra announced that it has expanded its Early Phase Center of Excellence to include institutional review board review capabilities for cosmetics research.

  February 14, 2022

   · 

  2 min read
• Global Leuprolide Acetate Market Opportunities and Growth Analysis Report

  The leuprolide acetate market has been projected to experience various growth opportunities during the forecast period.

  February 14, 2022

   · 

  5 min read
• Endodontics Devices Market Key Development and Future Opportunities Analysis

  The endodontic devices market has been anticipated to grow at a noticeable speed in the forthcoming years.

  February 14, 2022

   · 

  5 min read
• Pharm Country

  Cigna Corporation Announces Appearance at the Cowen 42nd Annual Health Care Conference

  Global health services company Cigna Corporation (NYSE:CI) announced today that Eric Palmer, president and chief executive officer of Evernorth, will present at the Cowen 42nd Annual Health Care Conference on March 7, 2022 through a virtual webcast.

  February 14, 2022

   · 

  1 min read
• Ambulatory Aids Market: The Walkers Segment is Projected to Account for a Significant Share of the Market

  Ambulatory devices are used for proper and stable ambulation in activities such as walking. A wide range of tools comes under the cover of ambulatory aids.

  February 14, 2022

   · 

  5 min read
• Viral Vectors Manufacturing Market: The genetic disorders segment is anticipated to dominate the market

  Gene therapy is one of the best treatment options for most chronic diseases. It involves inserting a functional copy of a gene into a defective cell.

  February 14, 2022

   · 

  5 min read
• Drug Development

  Oxurion Announces New Data on THR-149 Phase 2 Clinical Trial (“KALAHARI”) in DME at the Angiogenesis, Exudation, and Degeneration 2022 Conference

  Oxurion NV presented new data from Part A of its two-part Phase 2 Clinical Trial assessing THR-149 for treatment of diabetic macular edema at the Angiogenesis, Exudations, and Degeneration 2022 Meeting on February 11-12th.

  February 14, 2022

   · 

  6 min read
• Drug Development

  Azafaros Presents Positive Clinical and Preclinical Data Supporting Development of Lead Compound AZ-3102 in Lysosomal Storage Disorders at the 18th Annual WORLDSymposium™ Conference

  Azafaros B.V. announced positive clinical data from its first-in-human Phase 1 study with AZ-3102, the company’s lead program in development as a potential treatment for pediatric neurogenetic lysosomal storage disorders.

  February 14, 2022

   · 

  5 min read
• Genetown

  Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding

  Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive health, and precision oncology markets, announced they have secured $41.5M in funding.

  February 14, 2022

   · 

  2 min read
• Business

  Biodesix Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue (Unaudited)

  Biodesix, Inc. a leading data-driven diagnostic solutions company with a focus in lung disease, announced that the Company expects to report fourth quarter and record full-year 2021 preliminary unaudited total revenue of $7.2 million and $54.5 million, respectively.

  February 14, 2022

   · 

  5 min read